Anchor raises $10M, aims for more in Series B

Anchor Therapeutics has raised $10 million in the first close of what the company hopes will be a $30 million Series B round. Current investors TVM Capital, HealthCare Ventures and the Novartis Option Fund participated in the round. Anchor says it's in discussions with additional investors who may participate in the round. Anchor Therapeutics, known until earlier this year as Ascent Therapeutics, plans to pursue Big Pharma licensing pacts and its goal of raising a $30 million Series B round....